Knowledge and practices of pharmacists concerning off-label and on-label drug prescribing during pregnancy and breastfeeding: a study from the Kurdistan region, Iraq
Main Article Content
Abstract
Background: Off-label prescribing during pregnancy and breastfeeding is common due to limited approved medications, but it carries potential risks for both mother and child. Pharmacists play a key role in guiding safe drug use, yet gaps in knowledge and training may affect their ability to counsel effectively. This study was conducted to assess pharmacists’ knowledge of on-label and off-label drug use during pregnancy and breastfeeding, and to evaluate their practical recommendations for managing pregnancy-related and lactation-related conditions in Duhok Governorate of Iraq.
Methods: A Cross-sectional survey using questionnaires, carried out in pharmacies across Duhok Governorate between June 2024 and September 2024. Participants from 110 pharmacies were randomly selected, 82 pharmacists agreed to participate and completed a self-administered questionnaire.
Results: Among 82 pharmacists (74.5% response rate), familiarity with off-label prescribing was highest for Metformin (75.6%) and contraceptive pills (57.3%). Common on-label drugs were correctly identified as safe, including Amoxicillin (95.1%) and Methyldopa (89.0%). Pharmacists reported moderate confidence in advising pregnant and breastfeeding women on OTC medications and supplements, though knowledge gaps persisted, particularly for less commonly prescribed drugs and supplements. Many participants also perceived pharmacy college training on pregnancy and breastfeeding care as insufficient.
Conclusion: Pharmacists demonstrate overall awareness and moderate confidence in maternal drug counseling and clinical decision-making; however, gaps in knowledge and limited formal training highlight the need for targeted education and professional development to improve safe medication use during pregnancy and lactation.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Kateel R, Hegde S, Holla S. Mapping the therapeutic versatility of WHO essential medicines: a systematic analysis of off-label indications. Ther Adv Drug Saf. 2025 Nov 24;16:20420986251386215. DOI: 10.1177/20420986251386215.
2. Van Norman GA. Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities. JACC Basic Transl Sci. Elsevier Inc.; 2023;8(2):224. DOI: 10.1016/J.JACBTS.2022.12.011
3. Echeverría Gorriti A, Alzueta Istúriz N, García González P, Fernández González J, Sanz Álvarez L, Garjón Parra J. Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy? Gac Sanit. Ediciones Doyma, S.L.; 2023;37. DOI: 10.1016/j.gaceta.2022.102283
4. Blankart KE, Lichtenberg FR. Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study. J Pharm Policy Pract. Taylor and Francis Ltd.; 2025;18(1). DOI: 10.1080/20523211.2025.2472221
5. Trimm K, Moraga MT, Knäuper B, Rahme E, Gibson McDonald E, Tamblyn R. Off-Label Prescription of Benzodiazepines: A Retrospective Cohort Study of Prescribing Prevalence in Primary Care. Clinical Drug Investigation 2025 45:10. Springer; 2025;45(10):793–801. DOI: 10.1007/S40261-025-01476-1
6. Seong ES, Youn HJ, Chung JH, Choi JS, Han JY, Cho GJ, et al. Suggestion for Guidelines of Pregnancy Exposure Registry. Journal of the Korean Society of Maternal and Child Health. The Korean Society of Maternal and Child Health; 2018;22(3):125–30. DOI: 10.21896/JKSMCH.2018.22.3.125
7. Leung HY, Saini B, Ritchie HE. Medications and pregnancy: The role of community pharmacists - A descriptive study. PLoS One. PLoS One; 2018;13(5). DOI: 10.1371/JOURNAL.PONE.0195101
8. Brucker MC, King TL. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule. J Midwifery Womens Health. J Midwifery Womens Health; 2017;62(3):308–16. DOI: 10.1111/JMWH.12611
9. Pernia S, Demaagd G. The New Pregnancy and Lactation Labeling Rule. Pharmacy and Therapeutics [Internet]. Medi Media USA Inc; 2016 [cited 2025 Mar 25];41(11):713. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5083079/
10. Wyszynski DF, Shields KE. Frequency and type of medications and vaccines used during pregnancy. Obstet Med. Obstet Med; 2016;9(1):21–7. DOI: 10.1177/1753495X15604099
11. Saiyed MM, Ong PS, Chew L. Off-label drug use in oncology: a systematic review of literature. J Clin Pharm Ther. J Clin Pharm Ther; 2017;42(3):251–8. DOI: 10.1111/JCPT.12507
12. Falzon SM. Establishing a pharmacist-led helpline service for paediatric oncology patients. University of Malta; 2024 [cited 2026 Apr 18]; Available from: https://www.um.edu.mt/library/oar/handle/123456789/132981
13. Parzianello A, Fornasier G, Kiren V, Pigato F, Orzetti S, Zamagni G, et al. Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance. Pharmaceuticals (Basel). Pharmaceuticals (Basel); 2024;17(1). DOI: 10.3390/PH17010106
14. Iihara H, Hirose C, Funaguchi N, Endo J, Ito F, Yanase K, et al. Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy. Mol Clin Oncol. Spandidos Publications; 2021;14(6):116. DOI: 10.3892/MCO.2021.2278
15. Bernardi A, Pegoraro R. The ethics of off-label use of drugs: oncology pharmacy in Italy. J Clin Pharm Ther. J Clin Pharm Ther; 2008;33(2):95–9. DOI: 10.1111/J.1365-2710.2008.00902.X
16. Koni AA, Qashoa H, Musa AA, Masri M, Hazem W, Taha S, et al. Knowledge and practice of community pharmacists regarding the safety of drugs during pregnancy: a cross-sectional study from a developing country. BMC Pregnancy Childbirth. BioMed Central Ltd; 2024;24(1):189. DOI: 10.1186/S12884-024-06393-3
17. Ceulemans M, Liekens S, Van Calsteren K, Allegaert K, Foulon V. Community pharmacists’ attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation. Research in Social and Administrative Pharmacy. Elsevier Inc.; 2020;16(9):1192–200. DOI: 10.1016/j.sapharm.2019.12.010
18. Ceulemans M, Liekens S, Van Calsteren K, Allegaert K, Foulon V. Impact of a blended learning program on community pharmacists’ barriers, knowledge, and counseling practice with regard to preconception, pregnancy and lactation. Research in Social and Administrative Pharmacy. Elsevier Inc.; 2021;17(7):1242–9. DOI: 10.1016/J.SAPHARM.2020.09.009
19. Scott PA, Quotah OF, Dalrymple K V., White SL, Poston L, Farebrother J, et al. Community Pharmacist-Led Interventions to Improve Preconception and Pregnancy Health: A Systematic Review. Pharmacy. MDPI AG; 2021;9(4):171. DOI: 10.3390/PHARMACY9040171
20. Ayele AA, Islam MS, Cosh S, East L. Community pharmacy professionals’ practice in responding to minor symptoms experienced by pregnant women in Ethiopia: results from sequential mixed methods. J Pharm Policy Pract. BioMed Central Ltd; 2022;15(1):29. DOI: 10.1186/S40545-022-00427-X
21. Akkad ZA, Alomar M, Palaian S. An exploratory survey on community pharmacists’ service provision for pregnant and lactating women in Sharjah, United Arab Emirates. PLoS One. Public Library of Science; 2022;17(2):e0262254. DOI: 10.1371/JOURNAL.PONE.0262254
22. Yusuff KB, Makhlouf AM, Ibrahim MI. Community pharmacists’ management of minor ailments in developing countries: A systematic review of types, recommendations, information gathering and counselling practices. Int J Clin Pract. John Wiley & Sons, Ltd; 2021;75(10):e14424. DOI: 10.1111/IJCP.14424
23. Truong MBT, Ngo E, Ariansen H, Tsuyuki RT, Nordeng H. Community pharmacist counseling in early pregnancy—Results from the SafeStart feasibility study. PLoS One. Public Library of Science; 2019;14(7):e0219424. DOI: 10.1371/JOURNAL.PONE.0219424
24. Makki AA, Mohammed SH, Ahmedani EI, Yousef BA. Assessment of Knowledge and Attitude of Community Pharmacists towards of Label Medications in Khartoum State: A Descriptive Cross Sectional Study. J Pharm Res Int. Sciencedomain International; 2024;36(10):39–48. DOI: 10.9734/JPRI/2024/V36I107587
25. Basak R, McCaffrey DJ. Hospital pharmacists’ perceived beliefs and responsibilities in indication-based off-label prescribing. Int J Clin Pharm. Int J Clin Pharm; 2018;40(1):36–40. DOI: 10.1007/S11096-017-0567-7